Verastem, Inc.
For the period ended Dec 31, 2024. Filed Mar 20, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 20, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this 20th day of March 2025.
| | ||
|---|---|---|
| | VERASTEM, INC.By: | /s/ Daniel W. Paterson |
| | | Daniel W. Paterson |
| | | President and Chief Executive Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant in the capacities and on the dates indicated.
| Signature | Title | Date | ||
|---|---|---|---|---|
| /s/ Daniel W. Paterson | | | | |
| Daniel W. Paterson | | President, Chief Executive Officer and Director (Principal Executive Officer) | | March 20, 2025 |
| | | | | |
| /s/ Daniel Calkins | | | | |
| Daniel Calkins | | Chief Financial Officer(Principal Financial and Accounting officer) | | March 20, 2025 |
| | | | | |
| /s/ PAUL BUNN, M.D. | | | | |
| Paul Bunn, M.D. | | Director | | March 20, 2025 |
| | | | | |
| /s/ Robert Gagnon | | | | |
| Robert Gagnon | | Director | | March 20, 2025 |
| | | | | |
| /s/ Anil Kapur | | | | |
| Anil Kapur | | Director | | March 20, 2025 |
| | | | | |
| /s/ Michael Kauffman, M.D.,Ph.D. | | | | |
| Michael Kauffman, M.D., Ph.D. | | Director | | March 20, 2025 |
| | | | | |
| /s/ JOHN JOHNSON | | | | |
| John Johnson | | Director | | March 20, 2025 |
| | | | | |
| /s/ MICHELLE ROBERTSON | | | | |
| Michelle Robertson | | Director | | March 20, 2025 |
| | | | | |
| /s/ Eric Rowinsky, M.D. | | | | |
| Eric Rowinsky, M.D. | | Director | | March 20, 2025 |
| | | | | |
| /s/ BRIAN STUGLIK | | | | |
| Brian Stuglik | | Director | | March 20, 2025 |
| | | | | |
| /s/ Karin Tollefson | | | | |
| Karin Tollefson | | Director | | March 20, 2025 |
| | | | |
CONSOLIDATED FINANCIAL STATEMENTS
CONTENTS
| Report of Independent Registered Public Accounting Firm | F-2 |
|---|---|
| Consolidated Financial Statements | |
| Consolidated Balance Sheets | F-4 |
| Consolidated Statements of Operations and Comprehensive Loss | F-5 |
| Consolidated Statements of Stockholders’ (Deficit) Equity | F-6 |
| Consolidated Statements of Cash Flows | F-7 |
| Notes to Consolidated Financial Statements | F-8 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.